4.4 Article

New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015

Journal

DRUG AND ALCOHOL DEPENDENCE
Volume 161, Issue -, Pages 110-118

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.drugalcdep.2016.01.024

Keywords

New psychoactive substances; NPS; Synthetic cannabinoids; Synthetic cathinones; Tryptamines; Phenethylamines; Psychostimulants

Funding

  1. Australian Government Department of Health under the Substance Misuse Prevention and Service Improvement Grants [RG123583]

Ask authors/readers for more resources

Objective: To examine the rates and patterns of new psychoactive substance (NPS) use amongst regular psychostimulant users (RPU) in Australia. Method: Data were obtained from the 2010-2015 Ecstasy and related Drugs Reporting System (EDRS), which comprised a total cross-sectional sample of 4122 RPU. Results: Recent use of 'any' NPS increased from 33% in 2010 to 40% in 2015, although trends of use differed significantly across NPS classes. The correlates associated with NPS use also varied across NPS classes: frequent (i.e. weekly or more) ecstasy users were more likely to report recent phenethylamine use; LSD users were more likely to report recent phenethylamine and tryptamine use; and daily cannabis users were more likely to report recent synthetic cannabinoid use than RPU who had not used NPS. 'Poly' NPS consumers were found to be a particularly high risk group and were significantly more likely to be younger, male, report daily cannabis use, report weekly or more ecstasy use, report recent LSD use, have higher levels of poly drug use, have overdosed on any drug in the past year, and to have engaged in past month criminal activity. Conclusion: NPS use has been established as a significant and ongoing practice amongst our sample of RPU. It appears that RPU seek out NPS with similar properties to the illicit drugs that they are already consuming, with poly NPS consumers found to be a particularly high risk group. (c) 2016 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available